OncoGenex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mr_ssssamsa mr_ssssamsa • Jan 29, 2013 9:09 PM Flag

    ISIS

    The lifting of the curse on antisense -- "no antisense drug has ever been approved" (except for the treatment of an obscure eye disease many years ago, and I think that was by injection directly into the eye rather than systemically) -- can only be a good thing for OGXI.

    Sort:  Newest  |  Oldest  |  Most Replied Expand all replies
    • dr.kuvasz dr.kuvasz • Jan 30, 2013 7:07 AM Flag

      Hi Mr. Ssssamsa, if you go to Isis on Yahoo Finance, there are several good articles on the arrival of ASO drugs…New York Times and Forbes. As you say, can only boost OGXI profile leading to 011 release

    • boxcarlong boxcarlong • Jan 31, 2013 10:18 AM Flag

      antisense has arrived but the street still gives no respect to ISIS. All the negatives that have surrounded Kynarmo are still in the forefront with potential investors.

      They need to get over it or miss out what I think will be some nice upward PPS movement

      Over the next 2 years ISIS has several potential significant PPS drivers as its pipeline matures through P2B and some very $$$$big money deals are struck for these assets. EPS and within the biotech sector no need for cash thus dilution are still king with most investors.

      box.

 
OGXI
10.640.47(+4.62%)May 23 4:00 PMEDT